Bangladeshi (DSE) Pharma Industry Analysis
UpdatedJun 27, 2022
DataAggregated Company Financials
Companies16
- 7D-0.6%
- 3M-2.4%
- 1Y11.7%
- YTD-1.9%
The Pharma industry has been flat over the last week, but Beximco Pharmaceuticals has lost 3.1%. The past year has been better, since the industry has gained 12% in that time. Looking forward, earnings are forecast to grow by 12% annually.
Industry Valuation and Performance
Has the Bangladeshi Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Mon, 27 Jun 2022 | ৳532.9b | ৳172.6b | ৳34.7b | 21.5x |
| Wed, 25 May 2022 | ৳531.8b | ৳171.9b | ৳34.6b | 23x |
| Fri, 22 Apr 2022 | ৳561.8b | ৳169.2b | ৳34.3b | 24.9x |
| Sun, 20 Mar 2022 | ৳546.7b | ৳169.2b | ৳34.3b | 26.2x |
| Tue, 15 Feb 2022 | ৳570.6b | ৳169.3b | ৳34.4b | 23.8x |
| Thu, 13 Jan 2022 | ৳552.0b | ৳166.5b | ৳32.5b | 23.4x |
| Sat, 11 Dec 2021 | ৳557.5b | ৳157.6b | ৳30.0b | 27.1x |
| Mon, 08 Nov 2021 | ৳549.1b | ৳146.9b | ৳26.0b | n/a |
| Wed, 06 Oct 2021 | ৳597.1b | ৳145.3b | ৳25.4b | 29.7x |
| Fri, 03 Sep 2021 | ৳550.5b | ৳151.7b | ৳25.7b | 26.7x |
| Sun, 01 Aug 2021 | ৳519.7b | ৳151.7b | ৳25.7b | 26.2x |
| Wed, 05 May 2021 | ৳474.2b | ৳151.7b | ৳25.7b | 18.9x |
| Sat, 06 Feb 2021 | ৳470.5b | ৳148.4b | ৳24.6b | 21.7x |
| Tue, 10 Nov 2020 | ৳388.6b | ৳143.5b | ৳23.9b | 19.6x |
| Mon, 03 Aug 2020 | ৳348.5b | ৳139.4b | ৳23.0b | 19.2x |
| Thu, 07 May 2020 | ৳321.3b | ৳140.3b | ৳24.7b | 13.8x |
| Sun, 09 Feb 2020 | ৳347.7b | ৳135.7b | ৳24.7b | 15.4x |
| Sat, 02 Nov 2019 | ৳373.4b | ৳134.1b | ৳24.1b | 18.8x |
| Tue, 06 Aug 2019 | ৳382.6b | ৳131.0b | ৳23.7b | 17.5x |
Median PE Ratio
18.7x
Current Industry PE
- Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 16.8x.
- The industry is trading close to its 3-year average PS ratio of 3.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 14% per year over the last three years.
- Revenues for these companies have grown 9.6% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Bangladeshi Pharma compare with similar industries?
| BD Market | -0.47% | |
| Healthcare | -0.72% | |
| Pharma | -0.61% | |
| Pharma | -0.61% | |
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SQURPHARMA Square Pharmaceuticals | ৳215.80 | 0.5% +৳975.1m | 0.9% | PS10.3x | |
| ACMELAB ACME Laboratories | ৳87.50 | 0.8% +৳148.1m | 21.5% | PS9.3x | |
| IBNSINA IBN SINA Pharmaceutical Industry | ৳292.20 | 1.3% +৳115.6m | 19.5% | PS16.2x | |
| ORIONINFU Orion Infusion | ৳84.40 | 5.0% +৳81.4m | 27.1% | PS50.2x | |
| ACTIVEFINE Active Fine Chemicals | ৳21.10 | 0.5% +৳24.0m | 19.9% | PS92.3x |